Article info
Oral Presentations
Plenary session 9: young researcher session
09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma
Citation
09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma
Publication history
- First published September 21, 2022.
Online issue publication
September 21, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.